ClearPoint Capital, a family wealth management practice managing $224 million in client assets, joined the franchise channel of Ameriprise Financial,
20 Gene Therapy Clinical Trials Using the ClearPoint platform. Utilizes Razor / Blades Business Model.
Equities analysts expect ClearPoint Neuro, Inc. (NASDAQ:CLPT) to post earnings per share (EPS) of ($0.14) for the current quarter, according to Zacks. Two analysts have provided estimates for ClearPoi
MRI Software (“MRI”), a global leader in real estate software solutions, and Priority Technology Holdings, Inc. (NASDAQ: PRTH) (“Priority”), a leading
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q2 2020 Results Conference Call August 12, 2020 4:30 PM ET Company Participants Joe Burnett - CEO Harold Hurwitz - CFO Conference Call Participants Sall Yanchus -
Revenue Reaches $2.5 million Amid COVID-19 PandemicIRVINE, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) today announced financial results for its second fiscal quart
Release and Call After Market CloseIRVINE, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”) today announced that it will release financial results fo
This article will reflect on the compensation paid to Joe Burnett who has served as CEO of ClearPoint Neuro, Inc...
IRVINE, Calif., May 12, 2020 -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) today announced financial results for its first fiscal quarter ended March 31, 2020. Total revenues were.
ClearPoint Neuro, Inc. (CLPT) (the “Company”) today announced that it will release financial results for its 2020 first quarter, which ended March 31, 2020, on Tuesday, May 12, 2020 after the mark
ClearPoint Neuro, Inc. (CLPT) (the “Company”) today announced that it will release financial results for its 2020 first quarter, which ended March 31, 2020, on Tuesday, May 12, 2020 after the mark
ClearPoint Neuro, Inc. (CLPT) is pleased to announce that Matthew B. Klein, MD, MS, FACS, has been appointed to ClearPoint Neuro’s Board of Directors effective immediately. Dr. Klein, Chief Develop
ClearPoint Neuro, Inc. (CLPT) (the “Company”) today provided an update with respect to the COVID-19 pandemic and announced preliminary financial results for the quarter ended March 31, 2020. “G
NEW YORK (AP) — Changes announced in corporate dividends Feb. 10-Feb. 14. INCREASED DIVIDENDS Agnico Eagle Mines Ltd g .20 from .175 Ametek Inc .18 from .14 Auburn National .255 from .25 Avalonbay C
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE